![Luciana Borio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luciana Borio
Direktor/Vorstandsmitglied bei
EAGLE PHARMACEUTICALS, INC.
Vermögen: 659 090 $ am 30.06.2026
Profil
Luciana Borio is currently an Independent Director at Eagle Pharmaceuticals, Inc. and Insulet Corp.
since 2021.
Also since 2021, serving as Director at Paradigm Health, Inc., Venture Partner at ARCH Venture Partners LLC, and Trustee at Noblis, Inc. Formerly, Director-Medical & Biodefense Preparedness Policy at the National Security Council from 2017 to 2019.
Senior Vice President at In-Q-Tel, Inc. from 2019 to 2020.
Senior Associate at Johns Hopkins Center For Health Security from 2003 to 2008.
Chief Scientist at the US Food & Drug Administration from 2015 to 2017.
Education includes undergraduate studies at George Washington University and a doctorate from George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSULET CORPORATION 0.01% | 03.06.2026 | 4’329 ( 0.01% ) | 659 090 $ | 30.06.2026 |
Aktive Positionen von Luciana Borio
| Unternehmen | Position | Beginn |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.04.2021 |
| INSULET CORPORATION | Direktor/Vorstandsmitglied | 18.10.2021 |
Noblis, Inc.
 Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Direktor/Vorstandsmitglied | 25.10.2021 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01.12.2021 |
Paradigm Health, Inc.
 Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Luciana Borio
| Unternehmen | Position | Ende |
|---|---|---|
In-Q-Tel, Inc.
 In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | 01.01.2020 |
National Security Council | Corporate Officer/Principal | 01.01.2019 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01.01.2017 |
Johns Hopkins Center For Health Security
 Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Corporate Officer/Principal | 01.10.2008 |
Ausbildung von Luciana Borio
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noblis, Inc.
Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Commercial Services |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
In-Q-Tel, Inc.
In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Finance |
Johns Hopkins Center For Health Security
Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Commercial Services |
National Security Council | |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paradigm Health, Inc.
Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Technology Services |
Wählen Sie MarketScreener 
